141 related articles for article (PubMed ID: 21212584)
1. [Infliximab therapy for three adolescent patients with refractory Takayasu's arteritis].
Kaneko U; Kishi T; Kikuchi M; Hara R; Shinoki T; Miyamae T; Imagawa T; Mori M; Yokota S
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(6):317-23. PubMed ID: 21212584
[TBL] [Abstract][Full Text] [Related]
2. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.
Comarmond C; Plaisier E; Dahan K; Mirault T; Emmerich J; Amoura Z; Cacoub P; Saadoun D
Autoimmun Rev; 2012 Jul; 11(9):678-84. PubMed ID: 22155781
[TBL] [Abstract][Full Text] [Related]
3. Infliximab therapy in pediatric Takayasu's arteritis: report of two cases.
Buonuomo PS; Bracaglia C; Campana A; Insalaco A; Pardeo M; Cortis E; Ugazio AG
Rheumatol Int; 2011 Jan; 31(1):93-5. PubMed ID: 19851773
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab.
Quartuccio L; Schiavon F; Zuliani F; Carraro V; Catarsi E; Tavoni AG; Bombardieri S; Punzi L; De Vita S
Clin Exp Rheumatol; 2012; 30(6):922-8. PubMed ID: 23044074
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature.
Novikov PI; Smitienko IO; Moiseev SV
Clin Rheumatol; 2013 Dec; 32(12):1827-32. PubMed ID: 23995735
[TBL] [Abstract][Full Text] [Related]
6. Takayasu's arteritis progression on anti-TNF biologics: a case series.
Osman M; Aaron S; Noga M; Yacyshyn E
Clin Rheumatol; 2011 May; 30(5):703-6. PubMed ID: 21221688
[TBL] [Abstract][Full Text] [Related]
7. Successful golimumab therapy in four patients with refractory Takayasu's arteritis.
Suematsu R; Tashiro S; Ono N; Koarada S; Ohta A; Tada Y
Mod Rheumatol; 2018 Jul; 28(4):712-715. PubMed ID: 26707139
[TBL] [Abstract][Full Text] [Related]
8. Takayasu's arteritis in a patient with Crohn's disease: an unexpected association during infliximab therapy.
Katoh N; Kubota M; Shimojima Y; Ishii W; Matsuda M; Akamatsu T; Ikeda S
Intern Med; 2010; 49(2):179-82. PubMed ID: 20075586
[TBL] [Abstract][Full Text] [Related]
9. Refractory Takayasu arteritis successfully treated with infliximab.
Maffei S; Di Renzo M; Santoro S; Puccetti L; Pasqui AL
Eur Rev Med Pharmacol Sci; 2009; 13(1):63-5. PubMed ID: 19364087
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
Hoffman GS; Merkel PA; Brasington RD; Lenschow DJ; Liang P
Arthritis Rheum; 2004 Jul; 50(7):2296-304. PubMed ID: 15248230
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study.
Mekinian A; Néel A; Sibilia J; Cohen P; Connault J; Lambert M; Federici L; Berthier S; Fiessinger JN; Godeau B; Marie I; Guillevin L; Hamidou M; Fain O;
Rheumatology (Oxford); 2012 May; 51(5):882-6. PubMed ID: 22223706
[TBL] [Abstract][Full Text] [Related]
12. Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.
Tanaka F; Kawakami A; Iwanaga N; Tamai M; Izumi Y; Aratake K; Arima K; Kamachi M; Nakamura H; Huang M; Ida H; Origuchi T; Eguchi K
Intern Med; 2006; 45(5):313-6. PubMed ID: 16596001
[TBL] [Abstract][Full Text] [Related]
13. Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab.
Tatò F; Rieger J; Hoffmann U
Int Angiol; 2005 Sep; 24(3):304-7. PubMed ID: 16158044
[TBL] [Abstract][Full Text] [Related]
14. Infliximab in Takayasu arteritis: a safe alternative?
Karageorgaki ZT; Mavragani CP; Papathanasiou MA; Skopouli FN
Clin Rheumatol; 2007 Jun; 26(6):984-7. PubMed ID: 16633710
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab for Treating Takayasu's Arteritis and Associated Stroke: A Case Series and Updated Review of the Literature.
Osman M; Emery D; Yacyshyn E
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1291-8. PubMed ID: 25869777
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Takayasu's arteritis with tumor necrosis factor antagonists.
Filocamo G; Buoncompagni A; Viola S; Loy A; Malattia C; Ravelli A; Martini A
J Pediatr; 2008 Sep; 153(3):432-4. PubMed ID: 18718263
[TBL] [Abstract][Full Text] [Related]
18. Great Vessels of Children: Takayasu's Arteritis.
de Ranieri D
Pediatr Ann; 2015 Jun; 44(6):e148-52. PubMed ID: 26114370
[TBL] [Abstract][Full Text] [Related]
19. Effects of immunosuppressive and biological agents on refractory Takayasu arteritis patients unresponsive to glucocorticoid treatment.
Ohigashi H; Tamura N; Ebana Y; Harigai M; Maejima Y; Ashikaga T; Isobe M
J Cardiol; 2017 May; 69(5):774-778. PubMed ID: 27567177
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic update in large vessel vasculitides.
Pérez-Esteban S; González-Gay MA; Castañeda S
Rev Clin Esp (Barc); 2013 Oct; 213(7):338-46. PubMed ID: 23683962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
